Source: Therma Bright.
  • Therma Bright (THRM) has announced a C$6M private placement with institutional investors
  • The company will use the proceeds for general working capital purposes
  • It expects the placement to close on or about February 18, 2022
  • Therma Bright is a medical diagnostic and device technology company
  • Therma Bright (THRM) is down by 16.67 per cent trading at $0.3125 per share

Therma Bright (THRM) has announced a C$6M private placement with institutional investors.

The company will issue 20M units priced at $0.30 comprised of one common share and one common share purchase warrant.

Each warrant entitles the holder to purchase one common share for $0.375 for five years following the issuance date.

The company will use the proceeds for general working capital purposes.

It expects the placement to close on or about February 18, 2022.

H.C. Wainwright & Co. is acting as the exclusive placement agent.

Therma Bright is a medical diagnostic and device technology company. It developed the AcuVid COVID-19 Rapid Antigen Saliva Test.

Therma Bright (THRM) is down by 16.67 per cent trading at $0.3125 per share as of 12:43 pm EST.

More From The Market Online

Silver’s new supercycle: AI demand meets shrinking supply

Silver demand is exploding—AI data centres, solar, EVs, and advanced electronics are consuming silver faster than mines can supply it.

US Government bankrolls 5N Plus germanium production

5N Plus (TSX:VNP) will receive an US$18.1M grant from the US Government to expand its germanium recycling and refining operations in Utah.
Microsoft Vancouver office building

Microsoft shares drop as slowing cloud growth overshadows strong earnings

Microsoft (NASDAQ:MSFT) shares fell about 10 per cent after earnings, as investors focused on slowing Azure cloud growth.